Radlett, United Kingdom

Steven Tarran Jones


 

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 858(Granted Patents)


Company Filing History:


Years Active: 1998-2013

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovations of Steven Tarran Jones

Introduction

Steven Tarran Jones is a notable inventor based in Radlett, GB. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 14 patents to his name, Jones has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents are innovative compositions and methods for binding lysophosphatidic acid. This patent describes humanized anti-LPA monoclonal antibodies and their fragments and derivatives. Another significant patent focuses on humanized antibodies and compositions for binding sphingosine-1-phosphate. This invention relates to anti-S1P agents, particularly humanized monoclonal antibodies that are specifically reactive with S1P. These compositions are intended for use in treating diseases and conditions associated with aberrant levels of S1P.

Career Highlights

Throughout his career, Steven Tarran Jones has worked with various companies, including Lpath, Inc. and Curetech Ltd. His work has been instrumental in advancing the understanding and application of monoclonal antibodies in therapeutic settings.

Collaborations

Jones has collaborated with notable individuals in his field, including Roger A Sabbadini and William A Garland. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Steven Tarran Jones is a distinguished inventor whose work in humanized antibodies has the potential to impact medical treatments significantly. His contributions to biotechnology continue to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…